Abstract
This report describes the first heart transplantation recipient with acute biventricular heart failure symptoms caused by a post-myocarditis state, late after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. No other viral pathogens could be detected. Computed tomography angiography did not show cardiac allograft vasculopathy, and myocardial biopsy demonstrated no clinically relevant rejection. Subsequent cardiovascular magnetic resonance imaging revealed extensive epicardial delayed enhancement without myocardial edema. Heart failure medication was initiated and an implantable cardioverter defibrillator was implanted (due to non-sustained ventricular tachycardias), leading to a partial recovery of the ejection fraction. Further studies are needed to investigate the number of heart transplant recipients with myocardial damage after a SARS-CoV-2 infection.
Original language | English |
---|---|
Pages (from-to) | 34-36 |
Number of pages | 3 |
Journal | International Journal of Infectious Diseases |
Volume | 107 |
Early online date | 13 Apr 2021 |
DOIs | |
Publication status | Published - 1 Jun 2021 |
Bibliographical note
Funding Information:JJB declares a grant from Abbott outside the scope of this work. All other authors have no conflicts of interest to disclose.
Publisher Copyright:
© 2021 The Author(s)